home / stock / myl / myl news


MYL News and Press, Mylan N.V. From 04/17/20

Stock Information

Company Name: Mylan N.V.
Stock Symbol: MYL
Market: NASDAQ
Website: viatris.com

Menu

MYL MYL Quote MYL Short MYL News MYL Articles MYL Message Board
Get MYL Alerts

News, Short Squeeze, Breakout and More Instantly...

MYL - Carboplatin Market To Record an Exponential CAGR by 2029

New York City, NY: April 17, 2020 – Published via (Wired Release) – Recent Research and Future Market Potential of Carboplatin Market in Global Industry: 2020 Research and New Innovations in Pharmaceuticals and Healthcare Sector. The prime objective of the report is to offer upda...

MYL - Mylan Board Appoints Robert J. Coury As Executive Chairman of Mylan N.V.

HERTFORDSHIRE, England and PITTSBURGH , April 15, 2020 /PRNewswire/ -- The Mylan N.V. (NASDAQ: MYL) Board of Directors today announced the appointment of Robert J. Coury , previously chairman of the Mylan Board, to the position of executive chairman of Mylan. Given the unpreced...

MYL - Mylan Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of Mylan N.V. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm - MYL

NEW YORK, NY / ACCESSWIRE / April 14, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating whether the merger between Mylan N.V. (NASDAQ:MYL) and Pfizer Inc. is fair to Mylan shareholders. On July 29, 2019, Mylan and Pfizer announced a definitive agreement to combine ...

MYL - Better Coronavirus Stock: Moderna vs. Pfizer

Big pharmaceutical companies and small biotechs alike have jumped into the race to develop treatments and vaccines for the novel coronavirus disease COVID-19. Pfizer (NYSE: PFE) ranks as one of the biggest of the big pharma companies and has several COVID-19 efforts under way. Moderna (NA...

MYL - 3 Top Pharma Stocks to Buy in April

In most years, April isn't a special month to buy stocks. It's not a bad time to invest, but there's nothing that makes April better than other months. But this April is different.  Because of the coronavirus pandemic and the subsequent stock market plunge, this month is a very good time t...

MYL - Should Investors Take a Chance on Biogen?

Earlier this year, Biogen (NASDAQ: BIIB) dodged a bullet when it won a patent challenge to its multiple sclerosis (MS) drug, Tecfidera, in a lawsuit brought before the U.S. Patent Trial and Appeal Board by Mylan (NASDAQ: MYL) . Had Biogen lost this lawsuit, it would have meant seri...

MYL - Atovaquone and Proguanil Market Growth To Be Fuelled By 2020 to 2029

New York City, NY: April 09, 2020 – Recent Research and Future Market Potential of Atovaquone and Proguanil Market in Global Industry: 2020 Research and New Innovations in Pharmaceuticals and Healthcare Sector. The prime objective of the report is to offer updates and information relate...

MYL - Brazilian Hemorrhagic Fever (BzHF) Treatment Market To Rear Excessive Growth During 2029

New York City, NY: April 09, 2020 – Recent Research and Future Market Potential of Brazilian Hemorrhagic Fever (BzHF) Treatment Market in Global Industry: 2020 Research and New Innovations in Pharmaceuticals and Healthcare Sector. The prime objective of the report is to offer updates an...

MYL - Wall Street Breakfast: OPEC+ Virtual Meeting In The Spotlight

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha , iTunes , Stitcher and Spotify (click the highlighted links). Things are pretty tense in the oil markets ahead of a virtual meeting of the alliance of OPEC and non-O...

MYL - Mylan to donate 10M doses of malaria drug as production ramps up

Mylan N.V. ( MYL +5.7% ) announces that its production of malaria med hydroxychloroquine sulfate at its Morgantown, WV site has advanced ahead of schedule and has enabled the supply of additional product earlier than expected for COVID-19 patients. More news on: Mylan N.V., Healthcare ...

Previous 10 Next 10